These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31617407)

  • 1. Conservative Treatment Possibilities of Ménière Disease, Involving Vertigo Diaries.
    Molnár A; Maihoub S; Tamás L; Szirmai Á
    Ear Nose Throat J; 2021 Aug; 100(7):536-542. PubMed ID: 31617407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière's disease compared with betahistine pharmacotherapy.
    Molnár A; Maihoub S; Tamás L; Szirmai Á
    J Int Med Res; 2021 Apr; 49(4):300060520985647. PubMed ID: 33845616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study.
    Melnikov OA; Lilenko SV; Nauta J; Ouwens MJ
    Curr Med Res Opin; 2015 Nov; 31(11):1951-62. PubMed ID: 26121560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.
    Monzani D; Barillari MR; Alicandri Ciufelli M; Aggazzotti Cavazza E; Neri V; Presutti L; Genovese E
    Acta Otorhinolaryngol Ital; 2012 Dec; 32(6):393-403. PubMed ID: 23349559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
    Adrion C; Fischer CS; Wagner J; Gürkov R; Mansmann U; Strupp M;
    BMJ; 2016 Jan; 352():h6816. PubMed ID: 26797774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.
    Mira E; Guidetti G; Ghilardi L; Fattori B; Malannino N; Maiolino L; Mora R; Ottoboni S; Pagnini P; Leprini M; Pallestrini E; Passali D; Nuti D; Russolo M; Tirelli G; Simoncelli C; Brizi S; Vicini C; Frasconi P
    Eur Arch Otorhinolaryngol; 2003 Feb; 260(2):73-7. PubMed ID: 12582782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is betahistine effective for Ménière’s disease?
    Rosenbaum A; Winter M
    Medwave; 2017 Oct; 17(8):e7068. PubMed ID: 29099816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological management of vertigo in Meniere disease.
    Espinosa-Sanchez JM; Lopez-Escamez JA
    Expert Opin Pharmacother; 2020 Oct; 21(14):1753-1763. PubMed ID: 32539493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term therapy of Ménière's disease. Comparison of the effects of betahistine dihydrochloride and hydrochlorothiazide].
    Petermann W; Mulch G
    Fortschr Med; 1982 Mar; 100(10):431-5. PubMed ID: 7040186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease.
    Albu S; Chirtes F; Trombitas V; Nagy A; Marceanu L; Babighian G; Trabalzini F
    Am J Otolaryngol; 2015; 36(2):205-9. PubMed ID: 25510210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.
    Strupp M; Kraus L; Schautzer F; Rujescu D
    J Neurol; 2018 Oct; 265(Suppl 1):80-85. PubMed ID: 29532287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of vestibular vertigo and Ménière syndrome in outpatient clinics].
    Kostenko EV; Petrova LV; Torgovanova EA; Ganzhula PA; Lisenker LN; Otcheskaia OV; Khozova AA; Lebedeva AV; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):36-40. PubMed ID: 23388590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study.
    Oosterveld WJ
    J Laryngol Otol; 1984 Jan; 98(1):37-41. PubMed ID: 6363584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betahistine hydrochloride in Méniére's disease.
    Frew IJ; Menon GN
    Postgrad Med J; 1976 Aug; 52(610):501-3. PubMed ID: 790351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Betahistine treatment of Menière's disease (author's transl)].
    Chüden HG
    Laryngol Rhinol Otol (Stuttg); 1978 Nov; 57(11):997-1007. PubMed ID: 723406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine in the treatment of vertigo.
    Fischer AJ
    Acta Otolaryngol Suppl; 1991; 479():24-8. PubMed ID: 2068937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Menière's disease with betahistine (author's transl)].
    Stupp H; Kahl S
    HNO; 1976 Sep; 24(9):320-5. PubMed ID: 965272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betahistine in Ménière's disease.
    Wilmot TJ; Menon GN
    J Laryngol Otol; 1976 Sep; 90(9):833-40. PubMed ID: 787460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of the efficacy and safety of a new modified-release betahistine formulation in the treatment of vestibular vertigo and Meniere's disease].
    Parfenov VA; Zamergrad MV; Kazei DV; Nauta J
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12):42-48. PubMed ID: 33459540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.